These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15102675)

  • 1. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer.
    Pandya AY; Talley LI; Frost AR; Fitzgerald TJ; Trivedi V; Chakravarthy M; Chhieng DC; Grizzle WE; Engler JA; Krontiras H; Bland KI; LoBuglio AF; Lobo-Ruppert SM; Ruppert JM
    Clin Cancer Res; 2004 Apr; 10(8):2709-19. PubMed ID: 15102675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer.
    Pellikainen J; Kataja V; Ropponen K; Kellokoski J; Pietiläinen T; Böhm J; Eskelinen M; Kosma VM
    Clin Cancer Res; 2002 Nov; 8(11):3487-95. PubMed ID: 12429639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
    Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
    Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.
    Min KW; Kim DH; Do SI; Pyo JS; Chae SW; Sohn JH; Kim K; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kwon MJ; Moon KM
    Postgrad Med J; 2016 Dec; 92(1094):707-714. PubMed ID: 27222586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of expression of kruppel-like factor 4 and kruppel-like factor 5 with the clinical manifestations of breast cancer.
    Chen CJ; Lin SE; Lin YM; Lin SH; Chen DR; Chen CL
    Pathol Oncol Res; 2012 Apr; 18(2):161-8. PubMed ID: 21674249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
    Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
    Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
    Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
    Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear expression of KLF6 tumor suppressor factor is highly associated with overexpression of ERBB2 oncoprotein in ductal breast carcinomas.
    Gehrau RC; D'Astolfo DS; Dumur CI; Bocco JL; Koritschoner NP
    PLoS One; 2010 Jan; 5(1):e8929. PubMed ID: 20126619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast.
    Jin H; Ji M; Chen L; Liu Q; Che S; Xu M; Lin Z
    J Exp Clin Cancer Res; 2016 Mar; 35():42. PubMed ID: 26955804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis.
    Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Chikhlikar PR; Ghosh N; Trivedi TI
    Ann Surg Oncol; 2000 May; 7(4):305-11. PubMed ID: 10819372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis.
    Dolled-Filhart M; Camp RL; Kowalski DP; Smith BL; Rimm DL
    Clin Cancer Res; 2003 Feb; 9(2):594-600. PubMed ID: 12576423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of estrogen receptor-alpha and Ki67 in relation to pathological and molecular features in early-onset infiltrating ductal carcinoma.
    Ding SL; Sheu LF; Yu JC; Yang TL; Chen B; Leu FJ; Shen CY
    J Biomed Sci; 2004; 11(6):911-9. PubMed ID: 15591788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bax protein expression in DCIS of the breast in relation to invasive ductal carcinoma and other molecular markers.
    Rehman S; Crow J; Revell PA
    Pathol Oncol Res; 2000; 6(4):256-63. PubMed ID: 11173657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer.
    Zahnow CA; Younes P; Laucirica R; Rosen JM
    J Natl Cancer Inst; 1997 Dec; 89(24):1887-91. PubMed ID: 9414177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas.
    Jones J; Wang H; Karanam B; Theodore S; Dean-Colomb W; Welch DR; Grizzle W; Yates C
    Clin Exp Metastasis; 2014 Jun; 31(5):497-510. PubMed ID: 24570268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.
    Heinonen M; Bono P; Narko K; Chang SH; Lundin J; Joensuu H; Furneaux H; Hla T; Haglund C; Ristimäki A
    Cancer Res; 2005 Mar; 65(6):2157-61. PubMed ID: 15781626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear Klf4 accumulation is associated with cetuximab drug-resistance and predicts poor prognosis of nasopharyngeal carcinoma.
    Li X; Zhao Z; Yi S; Ma L; Li M; Liu M; Zhang Y; Liu G
    J Transl Med; 2018 Jul; 16(1):183. PubMed ID: 29973197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of alpha B crystallin and BCL2 in patients with infiltrating ductal carcinoma.
    Kim MS; Lee HW; Jun SY; Lee EH
    Int J Clin Exp Pathol; 2015; 8(8):8842-56. PubMed ID: 26464626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX2 overexpression is a prognostic marker for Stage III breast cancer.
    Kim HS; Moon HG; Han W; Yom CK; Kim WH; Kim JH; Noh DY
    Breast Cancer Res Treat; 2012 Feb; 132(1):51-9. PubMed ID: 21533532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kruppel-like factor 4 regulates laminin alpha 3A expression in mammary epithelial cells.
    Miller KA; Eklund EA; Peddinghaus ML; Cao Z; Fernandes N; Turk PW; Thimmapaya B; Weitzman SA
    J Biol Chem; 2001 Nov; 276(46):42863-8. PubMed ID: 11551969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.